---
title: "Rexulti (brexpiprazole) in major depressive disorder: Drug interactions questions"
description: "Drug interactions questions on Rexulti (brexpiprazole) in major depressive disorder, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: Does Rexulti need a dose change with fluoxetine or paroxetine? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/rexulti--major-depressive-disorder/drug-interactions"
published: "2026-11-13T03:43:41-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Rexulti (brexpiprazole) in major depressive disorder: Drug interactions questions

Manufacturer: Otsuka America Pharmaceutical, Inc.; Lundbeck  
Prescribing information: [Rexulti](https://www.otsuka-us.com/media/static/Rexulti-PI.pdf)

Drug interactions questions that apply to every indication of Rexulti are on [Rexulti (brexpiprazole), all indications: Drug interactions](https://www.evicenter.com/medical-information/rexulti/drug-interactions).

## Drug interactions

<a id="rexulti-ssri-cyp2d6"></a>

### Does Rexulti need a dose change with fluoxetine or paroxetine?

> “*In the clinical studies examining the use of REXULTI for the adjunctive treatment of MDD, dosage was not adjusted for strong CYP2D6 
> inhibitors (e.g., paroxetine, fluoxetine). Thus, CYP considerations are already factored into general dosing recommendations, and 
> REXULTI may be administered without dosage adjustment in patients with MDD.”

Source: [REXULTI: Prescribing information, page 5, captured 2026-11-13](https://www.otsuka-us.com/media/static/Rexulti-PI.pdf#page=5)

## Related pages
- [Medical information: Rexulti (brexpiprazole): Major depressive disorder](https://www.evicenter.com/medical-information/rexulti--major-depressive-disorder)
- [Indication](https://www.evicenter.com/medical-information/rexulti--major-depressive-disorder/indication)
- [Clinical trials](https://www.evicenter.com/medical-information/rexulti--major-depressive-disorder/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/rexulti--major-depressive-disorder/safety)
- [Specific populations](https://www.evicenter.com/medical-information/rexulti--major-depressive-disorder/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/rexulti--major-depressive-disorder/dosing-and-administration)
- [Access and coverage](https://www.evicenter.com/medical-information/rexulti--major-depressive-disorder/access-and-coverage)
